Applied Molecular Transport Announces Proposed Public Offering of Common Stock
March 29, 2021 16:11 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has...
Applied Molecular Transport Appoints Earl Douglas as General Counsel
March 22, 2021 08:00 ET
|
Applied Molecular Transport Inc.
Company continues to strengthen key functions of corporate leadership Company on track to announce oral AMT-101 top-line data readouts from the four Phase 2 trials from its comprehensive clinical...
Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
March 19, 2021 16:05 ET
|
Applied Molecular Transport Inc.
Successfully initiated four planned Phase 2 trials for oral AMT-101 with enrollment ongoing Company on track to announce oral AMT-101 top-line data readouts from the four Phase 2 trials from its...
Applied Molecular Transport to Present at Oppenheimer 31st Annual Healthcare Conference
March 09, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Expands Clinical Pipeline and Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126
March 01, 2021 08:00 ET
|
Applied Molecular Transport Inc.
Company expands pipeline with second clinical program, AMT-126, an oral IL-22 fusion biologic therapy for diseases associated with intestinal epithelial barrier defects IL-22 deficiency implicated in...
Applied Molecular Transport to Present at SVB Leerink 10th Annual Global Healthcare Conference
February 17, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Appoints Douglas Rich as Chief Technical Officer
January 19, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has...
Applied Molecular Transport to Present at Evercore ISI 3rd Annual HealthCONx Conference
November 24, 2020 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 12, 2020 16:05 ET
|
Applied Molecular Transport Inc.
- Company on track with comprehensive AMT-101 Phase 2 clinical program across multiple indications, including inflammatory bowel diseases and rheumatoid arthritis - - Announced dosing of first...
Applied Molecular Transport to Present at Jefferies Virtual London Healthcare Conference
November 11, 2020 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...